Fiscal Year End Company Status Exempt Flag March 31 Delist N Incorporation Locations Inc. Date Expiry Date Country Region Description 2/Apr/1980  5/Sep/2013  Canada      Exchange Filing Office Location (not available)		Business Type(s) Primary/Secondary Business Type Details Primary  *Timber Tract Operations  timber company    *Temporarily Unclassified  (not available)    *Consumer Products - Biotechnology/Pharmaceuticals  (not available)    *Research and Development in the Physical, Engineering and Life Sciences  Inflayzme is a Richmond, BC-based biopharmaceutical company focused on the dscovery, development and commercialization of drugs to treat serious inflammatory diseases such as asthma, rheumatoid arthritis, allergies, psoriasis and inflammatory bowl disease.  Secondary  *Research And Development In The Life Sciences  (not available)  Securities Symbol Security Name Market Status *ETR *Eacom Timber Corporation TSX Venture DELIST *ETR.H *Eacom Timber Corporation TSX Venture DELIST *IZP.H *Inflazyme Pharmaceuticals Ltd. TSX Venture DELIST *IZP *Inflazyme Pharmaceuticals Ltd. TSE DELIST *IZP *Inflazyme Pharmaceuticals Ltd. TSX Venture DELIST *IZP *Inflazyme Pharmaceuticals Ltd. VSE DELIST *IZP.WT *Inflazyme Pharmas Wt 9Se97 VSE DELIST *IZP.UN *Ut-Inflazyme Pharma Ltd VSE DELIST *IZP.RT *Inflazyme Pharmaceuticals Ltd rt 9se96 VSE DELIST *Inflazyme Pharmaceuticals Ltd rt VSE DELIST *IZP.WT.A *Inflazyme Pharmaceuticals Ltd. wts A 9De94 VSE DELIST *Inflazyme Pharmaceuticals Ltd. wts A 8De94 VSE DELIST *Inflazyme Pharmaceuticals Ltd. wts A 9De94 VSE DELIST *DPH *Dalphine Enterprises Ltd. VSE DELIST Name History From To *Eacom Timber Corporation 26/Aug/2008 5/Sep/2013 *Inflazyme Pharmaceuticals Ltd. 14/Nov/2007 25/Aug/2008 *Inflazyme Pharmaceuticals Ltd. 10/Dec/1993 23/Jun/2000 *Dalphine Enterprises Ltd. 2/Apr/1980 9/Dec/1993 Company Facts Reconciliation Subject Date Returned Summer 2013 CFR Not Received Associations Auditing Firm:  *Price Waterhouse Coopers LLP   *PricewaterhouseCoopers LLP Investor & Public Relastions:  *Dave Long Investor & Public Relations:  *John Long Investor Relations:  *Alan Davis Sponsor:  *Oliver (C.M.) & Company Ltd Subsidiary:  *Inflazyme Pharmaceuticals (Canada) Inc. Transfer Agent:  *Montreal Trust Company of Canada (Vancouver)   *Computershare Investor Services Inc.
Latest Information Type Date Title News Releases  5/Sep/2013  NEWS RELEASE - DELIST OFFER TO PURCHASE[MARKET NEWS]     NEWS RELEASE - IIROC TRADING HALT ETR[MARKET NEWS]     NEWS RELEASE - HALT[MARKET NEWS] Bulletins  5/Sep/2013  Delist-Offer to Purchase Meetings and Public Filings    Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations Location Name: *Operating Location  Area Name: *  Effective Date: 27/Jun/1997  Location Ownership Percent: 100  Expiry Date: 27/Dec/1997  Phone: (not available) Address: 2660 Oak Street Vancouver,British Columbia Canada V6H 3Z6 North America Fax: (not available) Description:   Location Name: *Operating Location (Richmond, BC)  Area Name: *  Effective Date: 1/Jul/1997  Location Ownership Percent: 100  Expiry Date: 23/Jun/2000  Phone: (800) 315-3660 (primary) Address: 425 - 5600 Parkwood Way Richmond,British Columbia Canada North America Fax: (604) 225-8711 (primary) Description:

* Historical Data